POST CONFERENCE MASTERCLASSES
FRIDAY 31 OCTOBER 2008
Drug Delivery Technologies, Licensing and Patent Strategies:
Commercial Perspectives
09:00 – 12:30
Course Description:
The market potential is very wide when we look at the third world; the developed nations
have the need for the life style drugs whereas the rest of the world needs cure from the
diseases, which have not been controlled for decades.
The R&D efforts worldwide are focused to evolve the technologies to provide the
medications for maximal effects with the reduction in side effects. The non-invasive routes
of administration, use of potent drugs, drug targeting and single shot therapies are the novel
systems on the horizon. The intellectual property protection, patents, collaborative research,
out-licensing and commercial arrangements only will emerge as the driving force
in the future.
There is need for research institutions, education professionals, scientists, technocrats and
marketing to come together on one platform and evolve strategies to make things available
for the mankind. The efforts will to ensure the complete clinical and toxicological studies are
conducted and regulatory approvals are sought to make the new delivery devices work for
the mankind at affordable cost.
Course Agenda:
- Developing a Novel Delivery System
- Therapeutic and Commercial Potential
- Licensing and Patent Strategy
- Exploring the Markets
- Road-map to Successful Introductions
Course Leader:
Dr Ashok Omray, Head, Drug Delivery Systems & Assoc. Vice President,
USV Ltd, India.
Strategic Alliance in Global Drug Delivery Market
14:00 – 17:30
Course Description:
The drug delivery market globally has witnessed a two digit growth in recent years
due to two key factors: uplifting of many regulations and advancements in technological
development and bio-engineering. Such growth is also backed up by different business
models which were not noted in the past – ie. emergence of independent businesses whose
main focus in on development of drug delivery technology (DDT) itself – as well as the
strategic alliances between these DDT and pharmaceutical companies. In this forum, the aim
is to take a close look at different types of business alliances manifesting globally and in
Korea to understand future growth direction in drug delivery technology business.
Course Agenda:
- Global drug delivery market– trend, size, challenges, drivers and restraints
- Key achievements in strategic alliances and partnership: Case studies
> US
> Europe
> Asia Pacific
> Korea
- Future prospective in global alliance
Course Leader:
Regina Hyoyoung Suh, Director, Asia Pacific, Healthcare,
Frost & Sullivan, Korea. |
